Predicting discontinuation of docetaxel treatment for metastatic castration-resistant prostate cancer (mCRPC) with random forest. - Daniel Kristiyanto; Kevin E. Anderson; Ling-Hong Hung; Ka Yee Yeung (F1000Research, 2016)